BIG CYPRESS ACQUISITION CORP.

Company

SAB Biotherapeutics, Inc.

Filed

October 19, 2021

Accession Number

0001104659-21-127418

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →